• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Model Number VBJR050702A
Device Problem Activation Failure (3270)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/07/2019
Event Type  malfunction  
Manufacturer Narrative
A review of the manufacturing records for the device verified the lot met all pre-release specifications.
 
Event Description
The following information was reported to gore: on (b)(6) 2019 a patient was undergoing treatment of a superficial femoral artery lesion with a gore® viabahn® endoprosthesis.Following advancement to the target location, deployment was initiated.The deployment line was pulled in a slow steady manner and it was noted that only approximately 1cm of the device had expanded when the deployment line broke.The line fragment was inspected and it appeared frayed.The physican then cut the delivery catheter open, but there was no deployment line to be found.An additional sheath was inserted and advanced to the partially expanded stent.The sheath was pushed up against the stent and this caused the stent to deploy the rest of the way.
 
Manufacturer Narrative
H.6.Results code 2: 213: the engineering evaluation stated the following: the following observations were made: the deployment knob, deployment line and part of the delivery catheter were returned.There was approximately 143 cm of deployment line between the hub and deployment knob.The deployment line had a single fiber coming off of the end of it that measured approximately 1 cm.There was approximately 52 cm of the delivery catheter returned including the distal shaft, upon which the endoprosthesis was mounted, and the distal tip.The delivery catheter was kinked approximately 4 and 36 cm away from the cut end of the delivery catheter.The delivery catheter appeared torn approximately 30 cm from the cut end of the of the delivery catheter for about 3 cm.The remainder of the device appears unremarkable.Engineering evaluation conclusion is inconclusive as it relates to the event description.Based on the device examination performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
 
Manufacturer Narrative
Additional manufacturing narrative: c1.Name (#1) - cbas® heparin surface; manufacturer/compounder: w.L.Gore & associates, inc.Lot #20799542.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9404802
MDR Text Key194021489
Report Number2017233-2019-01204
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00733132624089
UDI-Public00733132624089
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 08/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2022
Device Model NumberVBJR050702A
Device Catalogue NumberVBJR050702A
Device Lot Number20799542
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/13/2019
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/03/2019
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received01/01/2020
08/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-